InvestorsObserver
×
News Home

How Will the Market React to Chimerix Inc (CMRX) Stock Getting a Bullish Rating

Thursday, September 24, 2020 02:18 PM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to Chimerix Inc (CMRX) Stock Getting a Bullish Rating

The market has been high on Chimerix Inc (CMRX) stock recently. CMRX gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Chimerix Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CMRX!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With CMRX Stock Today?

Chimerix Inc (CMRX) stock is trading at $2.74 as of 2:03 PM on Thursday, Sep 24, a decline of -$0.27, or -8.83% from the previous closing price of $3.00. The stock has traded between $2.68 and $3.00 so far today. Volume today is low. So far 286,061 shares have traded compared to average volume of 474,496 shares.

To see the top 5 stocks in the Biotechnology industry click here.

More About Chimerix Inc

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes a treatment for acute myeloid leukemia (or AML) and an antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment--pharmaceuticals.

Click Here to get the full Stock Score Report on Chimerix Inc (CMRX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App